Hikma Differentiates With Succinylcholine Chloride PFS

Represents First Pre-Filled Syringe Formulation Version Launched In US

Hikma has debuted a pre-filled syringe formulation of succinylcholine chloride in the US, representing the first FDA-approved PFS version of the product to be launched in the market.

Hikma logo on phone, binary code in background
Hikma has launched the first pre-filled syringe formulation of succinylcholine chloride • Source: Shutterstock

Hikma has launched the first US Food and Drug Administration-approved pre-filled syringe version of succinylcholine chloride in the US, differentiating itself against the multiple versions of the 20mg/ml injectable already present in the US market.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Products

More from Generics Bulletin